【摘要】：目的探究應(yīng)用慷舒靈含銀抗菌敷料換藥對(duì)患者切口部位感染的預(yù)防控制效果,旨在為臨床預(yù)防和控制患者術(shù)后切口感染提供相應(yīng)的依據(jù)和經(jīng)驗(yàn)。方法選取2011年4月-2016年4月期間在醫(yī)院接受治療的行外科腹部疾病手術(shù)的患者602例,分為對(duì)照組和試驗(yàn)組,各301例;對(duì)照組患者采用常規(guī)的換藥方法;試驗(yàn)組患者采用慷舒靈含銀抗菌敷料換藥方法,在對(duì)照組常規(guī)清洗的基礎(chǔ)上,在患者傷口表面覆蓋慷舒靈含銀抗菌敷料,每2~3d換藥1次,直至患者切口愈合;兩組患者的疼痛程度采用VAS評(píng)分進(jìn)行比較;觀察比較兩組切口愈合時(shí)間、換藥費(fèi)用、VAS評(píng)分、換藥次數(shù)、SSI發(fā)生率、創(chuàng)緣反應(yīng)、創(chuàng)面滲出量比例及切口甲級(jí)愈合率。結(jié)果第二、三、四次換藥后,對(duì)照組創(chuàng)緣反應(yīng)及創(chuàng)面滲出量數(shù)據(jù)高于試驗(yàn)組,P均0.05;試驗(yàn)組患者與對(duì)照組患者在愈合時(shí)間、換藥費(fèi)用及次數(shù)的數(shù)據(jù)比較,試驗(yàn)組均小于對(duì)照組(P0.05);試驗(yàn)組患者的SSI發(fā)生率為1.99%,對(duì)照組患者的SSI發(fā)生率為9.97%,對(duì)照組SSI發(fā)生率高于試驗(yàn)組(P0.05);試驗(yàn)組患者的切口甲級(jí)愈合率為86.38%,對(duì)照組患者的切口甲級(jí)愈合率為73.09%,試驗(yàn)組患者的切口甲級(jí)愈合率高于對(duì)照組,數(shù)據(jù)差異具有統(tǒng)計(jì)學(xué)意義(P0.05);第四次換藥后試驗(yàn)組VAS評(píng)分為1.92±0.45,對(duì)照組VAS評(píng)分為4.11±0.62,試驗(yàn)組明顯低于對(duì)照組(P0.05)。結(jié)論應(yīng)用慷舒靈含銀抗菌敷料換藥能夠降低患者術(shù)后切口感染率,促進(jìn)切口愈合,減少換藥次數(shù),減輕經(jīng)濟(jì)負(fù)擔(dān),防控效果顯著,值得臨床推廣。
[Abstract]:Objective to investigate the preventive and control effect of Shengshuling silver antibacterial dressing on incision site infection in order to provide corresponding basis and experience for clinical prevention and control of postoperative incision infection. Methods 602 patients with abdominal diseases treated in hospital from April 2011 to April 2016 were divided into control group (n = 301) and experimental group (n = 301), and the patients in the control group were treated with routine dressing change method, and the patients in the control group were divided into control group (n = 301) and experimental group (n = 301). On the basis of routine cleaning in the control group, the patients in the experimental group were covered with Kangshuling silver antibacterial dressing every 2 days until the incision healed, and the pain degree of the two groups was compared with VAS score, and the pain degree of the two groups was compared with that of the control group, and the pain degree of the two groups was compared with that of the control group, and the pain degree of the patients in the two groups was compared with that of the control group. The wound healing time, dressing change cost, VAS score, dressing change times, SSI incidence, wound margin reaction, wound exudation ratio and incision grade A healing rate were observed and compared between the two groups. Results after the second, third and fourth dressing changes, the data of wound edge reaction and wound exudation in the control group were higher than those in the experimental group (P 0.05), and the healing time, dressing change cost and times in the experimental group were lower than those in the control group (P 0.05). The incidence of SSI was 1.99% in the experimental group and 9.97% in the control group, and the incidence of SSI in the control group was higher than that in the experimental group (P 0.05). The wound grade A healing rate in the experimental group was 86.38%, and that in the control group was 73.09%. The incision grade A healing rate in the experimental group was significantly higher than that in the control group (P 0.05). After the fourth dressing change, the VAS score of the experimental group was 1.92 鹵0.45, and that of the control group was 4.11 鹵0.62, which was significantly lower than that of the control group (P 0.05). Conclusion the application of Shengshuling silver antibacterial dressing can reduce the infection rate of incision, promote the healing of incision, reduce the times of dressing change, reduce the economic burden, and the effect of prevention and control is remarkable, which is worth popularizing in clinic.
【作者單位】： 山東大學(xué)附屬省立醫(yī)院外科;
【分類號(hào)】：R619.3

【相似文獻(xiàn)】

相關(guān)期刊論文 前5條

1 李云虎;;新型抗菌敷料對(duì)皮膚軟組織挫擦傷的療效觀察[J];皮膚病與性病;2013年01期

2 舒東;;手術(shù)切口應(yīng)用納米銀抗菌敷料的意義及機(jī)理探討[J];醫(yī)藥論壇雜志;2012年01期

3 付向陽;郭春蘭;;納米銀抗菌敷料在糖尿病并發(fā)淺表膿腫切開引流傷口換藥中的應(yīng)用[J];中華醫(yī)院感染學(xué)雜志;2011年09期

4 戴阿娟;殷雪群;鐘建華;;“潔悠神”長效抗菌敷料在肛瘺術(shù)后的應(yīng)用[J];中華護(hù)理雜志;2005年12期

5 ;[J];;年期

，

本文編號(hào)：2529168